423 related articles for article (PubMed ID: 25813361)
1. Polymeric nanoparticle drug delivery technologies for oral delivery applications.
Pridgen EM; Alexis F; Farokhzad OC
Expert Opin Drug Deliv; 2015; 12(9):1459-73. PubMed ID: 25813361
[TBL] [Abstract][Full Text] [Related]
2. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Ensign LM; Cone R; Hanes J
Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticle technologies for oral drug delivery.
Pridgen EM; Alexis F; Farokhzad OC
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1605-10. PubMed ID: 24981782
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal Responsive Polymeric Nanoparticles for Oral Delivery of Insulin: Optimized Preparation, Characterization, and In Vivo Evaluation.
Fang Y; Wang Q; Lin X; Jin X; Yang D; Gao S; Wang X; Yang M; Shi K
J Pharm Sci; 2019 Sep; 108(9):2994-3002. PubMed ID: 31047941
[TBL] [Abstract][Full Text] [Related]
5. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
Managuli RS; Raut SY; Reddy MS; Mutalik S
Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
[TBL] [Abstract][Full Text] [Related]
6. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
Chen MC; Sonaje K; Chen KJ; Sung HW
Biomaterials; 2011 Dec; 32(36):9826-38. PubMed ID: 21925726
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: an update.
Liu S; Wen X; Zhang X; Mao S
Expert Opin Drug Deliv; 2023; 20(10):1333-1347. PubMed ID: 37439101
[TBL] [Abstract][Full Text] [Related]
8. Oral delivery of nucleic acid therapeutics: Challenges, strategies, and opportunities.
Jiang X; Wang N; Liu C; Zhuo Y; Liang L; Gan Y; Yu M
Drug Discov Today; 2023 Apr; 28(4):103507. PubMed ID: 36690175
[TBL] [Abstract][Full Text] [Related]
9. Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug.
Fabiano A; Piras AM; Uccello-Barretta G; Balzano F; Cesari A; Testai L; Citi V; Zambito Y
Eur J Pharm Biopharm; 2018 Sep; 130():281-289. PubMed ID: 30006244
[TBL] [Abstract][Full Text] [Related]
10. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway.
Wang D; Jiang Q; Dong Z; Meng T; Hu F; Wang J; Yuan H
Adv Drug Deliv Rev; 2023 Dec; 203():115130. PubMed ID: 37913890
[TBL] [Abstract][Full Text] [Related]
12. Polymeric micelles for oral drug administration enabling locoregional and systemic treatments.
Simões SM; Figueiras AR; Veiga F; Concheiro A; Alvarez-Lorenzo C
Expert Opin Drug Deliv; 2015 Feb; 12(2):297-318. PubMed ID: 25227130
[TBL] [Abstract][Full Text] [Related]
13. Oral delivery of proteins by biodegradable nanoparticles.
Bakhru SH; Furtado S; Morello AP; Mathiowitz E
Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
[TBL] [Abstract][Full Text] [Related]
14. A review of biodegradable polymeric systems for oral insulin delivery.
Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Nanoparticle Transport across Intestinal Tissue: An Oral Delivery Perspective.
Ejazi SA; Louisthelmy R; Maisel K
ACS Nano; 2023 Jul; 17(14):13044-13061. PubMed ID: 37410891
[TBL] [Abstract][Full Text] [Related]
16. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
Lopes M; Shrestha N; Correia A; Shahbazi MA; Sarmento B; Hirvonen J; Veiga F; Seiça R; Ribeiro A; Santos HA
J Control Release; 2016 Jun; 232():29-41. PubMed ID: 27074369
[TBL] [Abstract][Full Text] [Related]
17. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
18. pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.
Liu L; Yao W; Rao Y; Lu X; Gao J
Drug Deliv; 2017 Nov; 24(1):569-581. PubMed ID: 28195032
[TBL] [Abstract][Full Text] [Related]
19. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
[TBL] [Abstract][Full Text] [Related]
20. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]